TCRX: Reports Positive Data
TScan Therapeutics announces positive initial data from cohort C of ongoing ALLOHA Phase 1 study evaluating TSC-101
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.